Skip to content

High-dose versus Low-dose Intravenous Nitroglycerin on Intubation Rate of Sympathetic Crashing Acute Pulmonary Edema in the Emergency Department

High-dose versus Low-dose Intravenous Nitroglycerin on Intubation Rate of Sympathetic Crashing Acute Pulmonary Edema in the Emergency Department

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240923005
Enrollment
140
Registered
2024-09-23
Start date
2024-11-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sympathetic crash acute pulmonary edema sympathetic crash acute pulmonary edema SCAPE nitroglycerine

Interventions

nitroglycerine 600 to 1000 mcg IV bolus then 100 mcg per min then titrate to achieve goal ,nitroglycerine 20-40 mcg per min then titrate to achieve goal
Experimental Drug,Active Comparator Drug
High dose nitroglycerine,Standard dose nitroglycerine

Sponsors

Routine to Research Unit (R2R) Siriraj Hoapital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult more than 18 years old with diagnosis of sympathetic crash acute pulmonary edema (according to diagnosed criteria)

Exclusion criteria

Exclusion criteria: 1. Cardiac arrest 2. Shock which are mean arterial pressure lower than 65 mmHg with signs of poor tissue perfusion 3. Intubation 4. Acute myocardial infarction 5. Acute aortic dissection 6. Pregnancy 7. Those who allergic to nitroglycerine or with absolute contraindication

Design outcomes

Primary

MeasureTime frame
Intubation 24 hours percent rate

Secondary

MeasureTime frame
resoltion of symptom 4 hours percent rate,Admission 24 hours percent rate,Complication Any time percent rate

Countries

Thailand

Contacts

Public ContactUsapan Surabenjawong

Department of Emergency Medicine, Siriraj Hospital Faculty of Medicine

usapan.sur@mahidol.ac.th024199216

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026